Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03194867
Brief Title: Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

First Submitted : June 19, 2017
First Submitted that Met QC Criteria : June 19, 2017
First Posted : June 21, 2017

Last Update Submitted that Met QC Criteria : January 9, 2020
Last Update Posted : January 13, 2020